IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Supriya Lifescience IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 700.00 Cr. The company is based in Mumbai and caters to Pharmaceutical sector. Axis Capital , ICICI Securities are the merchant bankers of Supriya Lifescience IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th May 2021.
Supriya Lifescience IPO posted revenues of ₹ 460.12 crores and PAT of ₹ 131.92 crores in FY22 on annualised basis.
Revenue:
₹ 449.60 Cr.
EBITDA Margin:
43.89
% 
Net Worth: ₹ 334.86 Cr.
Market Capitalisation:
[●]
P/E:
17.80 times
P/BV: [●]
EV/EBITDA: 0.35 times
Financial results of Supriya Lifescience IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Sep-21 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 504.10 | 445.82 | 336.43 | 253.05 | |
| Net Worth | 334.86 | 268.94 | 149.19 | 93.79 | |
| Total Debt | 70.99 | 67.41 | 79.07 | 85.34 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
224.80
449.60 |
385.37 | 311.64 | 277.84 | |
EBITDA
EBITDA on annualised basis |
98.67
197.34 |
178.15 | 109.45 | 72.76 | |
PAT
PAT on annualised basis |
65.96
131.92 |
123.83 | 73.40 | 39.42 | |
Supriya Lifescience IPO PAT Margin is 29.34 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Supriya Lifescience IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Sep-21 | FY21 | FY20 | FY19 |
|---|---|---|---|---|
| EBITDA Margin (%) | 43.89 | 46.23 | 35.12 | 26.19 |
| PAT Margin (%) | 29.34 | 32.13 | 23.55 | 14.19 |
| EPS (₹) | 9.01 | 16.92 | 10.03 | 5.39 |
| ROE (%) | 19.70 | 46.04 | 49.20 | 42.03 |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 13.08 | 27.78 | 21.82 | 15.58 |
| Debt to Equity | 0.21 | 0.25 | 0.53 | 0.91 |
The market Capitalisation of Supriya Lifescience IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Supriya Lifescience IPO prospectus highlights an Return on Equity (ROE) of 19.70 % , Return on Assets (ROA) of 13.08 %, and an EBITDA Margin of 43.89 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Supriya Lifescience IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Supriya Lifescience IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Supriya Lifescience IPO has a Price-to-Earnings (PE) ratio of 17.80 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Supriya Lifescience IPO reported revenue of ₹ 460.12 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Supriya Lifescience IPO provide insights into sales growth, market demand, and business scalability.
Supriya Lifescience recorded an EBITDA of ₹ 197.34 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Supriya Lifescience Profit After Tax (PAT) is ₹ 131.92 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 449.60 Cr.
EBITDA Margin:
43.89
%
Net Worth: ₹ 334.86 Cr.
Market Capitalisation:
[●]
P/E:
17.80 times
P/BV: [●]
EV/EBITDA: 0.35 times
Supriya Lifescience operates in Pharmaceutical and Manufacturers And Suppliers Of Active Pharmaceuticals. The Issue is listed on BSE,NSE in Dec, 2021. Supriya Lifescience IPO size was 700.00 with Issue price of 274.00 .
Merchant Banker(s) of Supriya Lifescience IPO: Axis Capital Limited , ICICI Securities Limited
Supriya Lifescience IPO subscription was 71.51 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Supriya Lifescience IPO listed at a listing price of 390.35 against the offer price of 274.00.
The current market price of Supriya Lifescience is 726.00.
Why Us?
